SSY Group Limited is one of the leading pharmaceutical manufacturers in China with nearly 7 decades of operation history and a well-established brand name. The Group went public on the Hong Kong Stock Exchange in December 2005 with stock code 2005. The group has become a component stock of Morgan Stanley Capital International Index (MSCI) China Index from June 2018. The Group is principally engaged in the research, development, manufacture and sale of a wide range of pharmaceutical products, including OTC drugs, bulk medicine and medical materials, mainly intravenous infusion solution to hospital and distributors. The manufacturing plants of the Group locates in Hebei Province and Jiangsu Province in China, its products take leading position in the high-end hospital market in China.
View Top Employees from SSY Group Limited| Website | http://www.ssygroup.com.hk |
| Revenue | $533 million |
| Employees | View employees |
| Founded | 2004 |
| Address | Rooms 4902-03, 49Th Fl, Central Plz, Hong Kong, Central and Western, CN |
| Industry | Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Web Rank | 22 Million |
| Keywords | Pharma Manufacturing Companies In Hong Kong, 石四藥集團 |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular SSY Group Limited employee's phone or email?
SSY Group Limited Questions
The SSY Group Limited annual revenue was $533 million in 2023.
SSY Group Limited is based in Hong Kong, Central and Western.
The NAICS codes for SSY Group Limited are [3254, 32541, 32, 325].
The SIC codes for SSY Group Limited are [283, 28].
Related Companies
